Dr. Mark Drazner, an advanced heart failure and transplant cardiologist, joins Dr. Hirsh Elhence, a medicine resident, and Dr. Mark Belkin from the University of Chicago. They explore the management of heart failure with a focus on device indications after myocardial infarction. Key discussions highlight the role of implantable cardioverter-defibrillators for sudden cardiac death prevention and the criteria for cardiac resynchronization therapy. They also navigate the complex decisions around life vests and ensure patient-centered approaches in heart failure management.

In this engaging discussion, lipid scholars Oby Ibe from Temple University and Elizabeth Epstein from Scripps Clinic, along with expert Jessica Pena, dive into a complex case of a 63-year-old man with elevated lipoprotein(a) levels and multiple cardiovascular risks. They explore the case's twists, including a flail mitral valve and pulmonary edema. The conversation also highlights advancements in cardiovascular risk assessments and the importance of personalized treatment strategies, showcasing the vital role of mentorship in shaping future lipidologists.

In this insightful discussion, Dr. Biykem Bozkurt, an expert in heart failure and a leading professor, joins internal medicine resident Dr. Hirsh Elhence and Dr. Mark Belkin, Co-Chair for a cardiology series. They delve into 2022 heart failure management guidelines, emphasizing effective screening for at-risk individuals. A case study highlights the importance of natriuretic peptide biomarkers. The trio discusses innovative strategies for screening high-risk patients and the shifting role of imaging and digital technologies in cardiac assessment.

Dr. Muthiah Vaduganathan, an expert on SGLT inhibition, shares insights into its remarkable benefits for cardiovascular and kidney health beyond diabetes. He explains how SGLT2 inhibitors significantly lower cardiovascular mortality and hospitalization for heart failure. The conversation highlights their effectiveness in diverse patient populations, including those with chronic kidney disease and myocardial infarction. The podcast dives into the need for a streamlined approach to treatment while emphasizing the innovative role of these inhibitors in modern cardiology.

Dr. Heval Kelli shares his journey from refugee to cardiologist, advocating for underserved communities. Topics include inclusivity in cardiology, mentorship, advocacy for refugee health, and empowering immigrant and refugee communities in medicine. The conversation emphasizes compassion, empathy, and the importance of diversity in healthcare.

CardioNerds co-founder Dan Ambinder joins a group from the University of Rochester for a day on Lake Ontario. They discuss a case involving a patient with papillary muscle rupture presenting with acute dyspnea. Details include an echo revealing a flail anterior mitral valve leaflet, cardiac cath revealing an occluded distal RCA, and subsequent management with an IABP. The case delves into the challenges of managing severe mitral regurgitation due to papillary muscle rupture.

Dr. Katherine Tuttle discusses the biology of SGLT inhibitors, their impact on cardiology, nephrology, and diabetes. Topics include optimizing medication regimen, management and monitoring of SGLT2 inhibitors, challenges of utilizing them in clinical practice, and benefits for heart failure and CKD patients.

Drs. Suleiman, Elliott, and Osude share their cardiology journeys. They discuss a complex case of severe mitral paravalvular regurgitation with hemolytic anemia. Topics include valve complications, fluoroscopy, and management strategies for prosthetic valve patients.

Dr. Nausheen Akhter discusses multi-modality imaging in cardio-oncology. Topics include monitoring LVEF with nuclear imaging, using MRI for cardiotoxic therapy surveillance, identifying coronary disease with CT, and diagnosing cardiac amyloidosis. The episode emphasizes the role of imaging in managing cardiotoxicity during cancer treatment and long-term surveillance strategies.

Dr. Brett Wanamaker and specialists discuss a challenging case of pericardial decompression syndrome in a woman with metastatic lung cancer, emphasizing pericardiocentesis complications, differential diagnoses, and management strategies. They explore the complexities of post-procedural hemodynamic issues and the importance of echocardiography in diagnosis and treatment.